 |
THOMAS P. KOESTLER,
PH.D.
Executive Vice President and President
Schering-Plough Research Institute
Schering-Plough Corporation
Kenilworth, New Jersey
Thomas P. Koestler, Ph.D., is executive vice president and president
of Schering-Plough Research Institute (SPRI), the pharmaceutical
research arm of Schering-Plough Corporation.
Koestler is responsible for all aspects of SPRI, including heading
up the Pharmaceutical Leadership Board (PLB). The PLB guides the
strategic direction of product development programs and oversees
the movement of projects through the development, registration and
launch phases.
He joined Schering-Plough in August 2003 and most recently was executive
vice president, Global Development, SPRI. In this position, he was
responsible for setting strategic direction and implementation plans
for the new development organization, including worldwide clinical
development, pharmaceutical sciences, global regulatory affairs
and global project management.
Before joining Schering-Plough, he was senior vice president and
head of global regulatory affairs for Pharmacia Corporation. Prior
to joining Pharmacia, Koestler was senior vice president and global
head, drug regulatory affairs, compliance assurance, clinical safety
and epidemiology for Novartis. Before that appointment, he was senior
director, drug regulatory affairs, at Ortho McNeil and a director
of regulatory affairs at Bristol-Myers Squibb.
Koestler received his Ph.D. degree from the State University of
New York (SUNY) at Buffalo, Roswell Park Memorial Institute, where
he studied medicine and pathology. He holds a B.S. degree in biology
from Daeman College, Amherst, N.Y.
Koestler has been published extensively in medical journals and
is a member of numerous professional associations. He also is involved
in community affairs and serves as vice chairman and an officer
of the Children’s Specialized Hospital Foundation in Mountainside,
N.J.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
|
|
